Best GLP-1 Providers Under the Medicare Bridge Program
The Medicare GLP-1 Bridge launched July 1, 2026, targeting a $50/month copay for eligible Part D beneficiaries. Here's which providers are actually positioned to work with that program.
What matters for Medicare Bridge eligibility
The Bridge program covers FDA-approved brand-name medications through participating Part D plans — compounded medications aren't part of this program, since Medicare requires an FDA-approved product with an assigned NDC. That immediately narrows the relevant field to brand-name-only providers.
Sesame Care From $149
Prescribes FDA-approved brand-name medications (Wegovy, Ozempic, Zepbound) — the pathway compatible with Medicare Bridge eligibility.
If you're not Bridge-eligible or your plan hasn't opted in
Not every Part D plan is participating at launch. If yours isn't yet, or you don't meet the eligibility criteria, compounded options remain a cash-pay alternative worth comparing.
Wellorithm From $147
Compounded semaglutide and tirzepatide — a cash-pay alternative if Bridge eligibility doesn't apply to your situation.
The practical first step
Before comparing providers on this basis, confirm your specific Part D plan's Bridge participation status directly through Medicare.gov or your plan administrator — that determines which category of provider is actually relevant to your situation.